| __timestamp | Pharming Group N.V. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 612613000000 |
| Thursday, January 1, 2015 | 5279557 | 650773000000 |
| Friday, January 1, 2016 | 8073913 | 619061000000 |
| Sunday, January 1, 2017 | 44864073 | 628106000000 |
| Monday, January 1, 2018 | 53488904 | 717599000000 |
| Tuesday, January 1, 2019 | 65896361 | 964737000000 |
| Wednesday, January 1, 2020 | 69968267 | 875663000000 |
| Friday, January 1, 2021 | 92047281 | 886361000000 |
| Saturday, January 1, 2022 | 131819000 | 997309000000 |
| Sunday, January 1, 2023 | 87501000 | 1053819000000 |
| Monday, January 1, 2024 | 1053819000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry giants: Takeda Pharmaceutical Company Limited and Pharming Group N.V., from 2014 to 2023. Over this period, Takeda's SG&A expenses have consistently dwarfed those of Pharming, highlighting a stark contrast in operational scale and strategy. In 2023, Takeda's expenses reached a staggering 1.05 trillion, marking a 72% increase from 2014. Meanwhile, Pharming's expenses, though significantly smaller, surged by over 2,000% during the same period, reflecting its aggressive growth strategy. Notably, 2024 data for Pharming is missing, indicating potential reporting delays or strategic shifts. This comparison underscores the diverse approaches within the pharmaceutical sector, where scale and agility play crucial roles in shaping financial strategies.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Pharming Group N.V.
Amgen Inc. or Takeda Pharmaceutical Company Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Neurocrine Biosciences, Inc. Trends and Insights
Breaking Down Revenue Trends: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited or Dynavax Technologies Corporation: Who Manages SG&A Costs Better?
Biogen Inc. or Pharming Group N.V.: Who Manages SG&A Costs Better?
Genmab A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Pharming Group N.V. vs Apellis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.